We bring you the latest news from the healthcare about the health care in the United Kingdom.

woensdag 24 januari 2018

Nature Reviews Rheumatology - Table of Contents alert Volume 14 Issue 2

If you are unable to see the message below, click here to view.
Nature Reviews Rheumatology APLAR
 

Advertisement
We outperform all six government measures on survival rates. 

Learn why so many doctors trust us for their most complex cases. 


Discover More >
 
TABLE OF CONTENTS
 
February 2018 Volume 14 Number 2 Advertisement
 
Nature Reviews Rheumatology cover
2016 2-year Impact Factor 12.188 Journal Metrics 2-year Median 7
In this issue
Research Highlights
Year in Review
Reviews
 
Also this month
 Featured article:
Moving towards a molecular taxonomy of autoimmune rheumatic diseases
Guillermo Barturen, Lorenzo Beretta, Ricard Cervera, Ronald Van Vollenhoven & Marta E. Alarcón-Riquelme

 
 
Do you have a career question?
The Naturejobs podcast features one-on-one Q&As, panel discussions and other exclusive content to help scientists with their careers. Hosted on the Naturejobs blog, the podcast is also available on iTunes and Soundcloud.

Listen today!

 
Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
   
RESEARCH HIGHLIGHTS
 
Top

Systemic sclerosis: Promoting apoptosis is key to reversing fibrosis
Published online: 24 January 2018
p61 | doi:10.1038/nrrheum.2017.222

PDF


Acute inflammatory arthritis: Long-term effects of chikungunya
Published online: 24 January 2018
p62 | doi:10.1038/nrrheum.2017.223

PDF


Autoinflammatory diseases: TNF drives cryopyrinopathies in mice
Published online: 03 January 2018
p63 | doi:10.1038/nrrheum.2017.217

PDF


Rheumatoid arthritis: IFNγ drives synovial tissue remodelling
Published online: 11 January 2018
p63 | doi:10.1038/nrrheum.2017.221

PDF


Experimental arthritis: Anti-TNF kills the macrophage response
Published online: 24 January 2018
p64 | doi:10.1038/nrrheum.2017.207

PDF


Inflammation: Potassium channel regulates osteoclastogenesis
Published online: 24 January 2018
p64 | doi:10.1038/nrrheum.2018.7

PDF


 


IN BRIEF

Osteoarthritis: Arthroscopy does not delay TKA for knee OA | Therapy: Biologics and risk of second malignant neoplasm | Rheumatoid arthritis: Higher disease risk in children of women with RA | Systemic lupus erythematosus: Rituximab improves SLE disease activity
PDF

Nature Reviews Rheumatology
JOBS of the week
Post Doctoral Researcher
The Ohio State University Comprehensive Cancer Center and Colleage of Medicine
Postdoctoral Research Associate
Benaroya Research Institute at Virginia Mason (BRI)
Postdoctral Fellow
Boston University School of Medicine, BUMC
Open Rank, Term Tenure Track
The University of Texas MD Anderson Cancer Center
Postdoctoral position
Stockholm University
More Science jobs from
Nature Reviews Rheumatology
EVENT
EULAR 2018 - Annual European Congress of Rheumatology
13.06.18
Amsterdam, Netherlands
More science events from
 
YEAR IN REVIEW
 
Top
Inflammation in 2017: Connectivity to other fields brings new ideas
Pierre Miossec

Published online: 11 January 2018
p65 | doi:10.1038/nrrheum.2017.215

Multiple scientific fields pertaining to inflammation, including the fields of cardiovascular, infection and cancer research, are increasingly contributing to our understanding of rheumatoid arthritis (RA). In 2017, such research has helped develop our understanding of RA comorbidity, the link between RA pathogenesis and infection, and the effects of new therapies.
Full Text | PDF

 
Osteoporosis in 2017: Addressing the crisis in the treatment of osteoporosis
Christian Roux & Karine Briot

Published online: 11 January 2018
p67 | doi:10.1038/nrrheum.2017.218

A large number of patients with osteoporosis are not receiving appropriate treatment, due in part to concerns regarding drug safety. Great progress has been made to address this crisis in therapy in 2017, including highlighting the patients' views, developing new therapies and treatment strategies and addressing these safety concerns.
Full Text | PDF

 
Paediatric rheumatology in 2017: Child-centred research is the key to progress
Michael W. Beresford & Athimalaipet V. Ramanan

Published online: 11 January 2018
p69 | doi:10.1038/nrrheum.2017.214

The rarity, severity and complexity of paediatric rheumatic diseases make progress in treating these diseases a challenge. In 2017, a new series of recommendations for treatment, studies that unravel the complexity of juvenile idiopathic arthritis and clinical trials that tackle sight-threatening uveitis have helped to improve paediatric care.
Full Text | PDF

 
Rheumatoid arthritis in 2017: Protective dietary and hormonal factors brought to light
Jeffrey A. Sparks & Karen H. Costenbader

Published online: 11 January 2018
p71 | doi:10.1038/nrrheum.2017.216

Tremendous progress has been made in the identification of rheumatoid arthritis (RA) risk factors in 2017. The results of epidemiological studies highlighted dietary and hormonal factors that are associated with slowing the transition from one preclinical phase of RA to another, potentially protecting individuals from developing RA.
Full Text | PDF

 
Osteoarthritis in 2017: Latest advances in the management of knee OA
Timothy E. McAlindon & Raveendhara R. Bannuru

Published online: 11 January 2018
p73 | doi:10.1038/nrrheum.2017.219

Osteoarthritis research in 2017 provided new insights into the long-term effects of intra-articular glucocorticoids, and also led to the approval of a novel, longer-lasting glucocorticoid formulation. New drugs for the treatment of osteoarthritis also emerged this year, including a small-molecule inhibitor of the Wnt signalling pathway.
Full Text | PDF

 
 
 
REVIEWS
 
Top
Moving towards a molecular taxonomy of autoimmune rheumatic diseases
Guillermo Barturen, Lorenzo Beretta, Ricard Cervera, Ronald Van Vollenhoven & Marta E. Alarcón-Riquelme

Published online: 24 January 2018
p75 | doi:10.1038/nrrheum.2017.220

The heterogeneity of autoimmune rheumatic diseases, and their shared clinical and molecular features, makes classifying and diagnosing these diseases difficult and highlights the need for a new taxonomy. Reclassifying these diseases according to the underlying molecular mechanisms might lead to novel insights into disease mechanisms and enable better patient stratification.
Abstract | Full Text | PDF | Supplementary information

 
Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis
Echoe M. Bouta, Richard D. Bell, Homaira Rahimi, Lianping Xing, Ronald W. Wood, Clifton O. Bingham III, Christopher T. Ritchlin & Edward M. Schwarz

Published online: 11 January 2018
p94 | doi:10.1038/nrrheum.2017.205

Preclinical studies suggest that the lymphatic system has a critical role in the pathogenesis and therapy of inflammatory-erosive arthritis. These findings, and complementary data from human studies, highlight the translational potential of assessing and modulating the lymphatic system in patients with chronic arthritis.
Abstract | Full Text | PDF | Supplementary information

 
Behçet syndrome: a contemporary view
Hasan Yazici, Emire Seyahi, Gulen Hatemi & Yusuf Yazici

Published online: 03 January 2018
p107 | doi:10.1038/nrrheum.2017.208

In this Review, the authors discuss the emerging evidence of the aetiology of Behçet's. They argue that geographical variation in prevalence, variation in disease expression and evidence of clinical subsets supports the notion that Behçet's is a syndrome rather than a disease.
Abstract | Full Text | PDF

 
Corrigendum: Behçet syndrome: a contemporary view
Hasan Yazici, Emire Seyahi, Gulen Hatemi & Yusuf Yazici

Published online: 24 January 2018
p119 | doi:10.1038/nrrheum.2018.3

Full Text | PDF
 
Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaboration
Andrew P. Cope, Michael R. Barnes, Alexandra Belson, Michael Binks, Sarah Brockbank, Francisco Bonachela-Capdevila, Claudio Carini, Benjamin A. Fisher, Carl S. Goodyear, Paul Emery, Michael R. Ehrenstein, Neil Gozzard, Ray Harris, Sally Hollis, Sarah Keidel, Marc Levesque, Catharina Lindholm, Michael F. McDermott, Iain B. McInnes, Christopher M. Mela, Gerry Parker, Simon Read, Ayako Wakatsuki Pedersen, Frederique Ponchel, Duncan Porter, Ravi Rao, Anthony Rowe, Peter Schulze-Knappe, Matthew A. Sleeman, Deborah Symmons, Peter C. Taylor, Brian Tom, Wayne Tsuji, Denny Verbeeck, John D. Isaacs & The RA-MAP Consortium

Published online: 24 January 2018
p119 | doi:10.1038/nrrheum.2018.6

Full Text | PDF
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events
Nature Reviews Rheumatology was previously published as Nature Clinical Practice Rheumatology.
 

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our feedback department

Springer Nature | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature